Maria Elena Gasperini, Director of Sustainability Life Sciences, Jacobs discuses the ways in which the biopharma industry can build a sustainable future in our latest EPM Online Insight.
Blackstone have announced a new collaboration with Moderna through a development and commercialisation funding agreement where funds managed by Blackstone Life Sciences and will provide up to $750 million to fund Moderna’s influenza program.
MSD have announced that the U.S. FDA has approved sotatercept-csrk (U.S. Brand Name: WINREVAIR, for injection, 45mg, 60mg) for the treatment of adults with pulmonary arterial hypertension.
Otsuka Pharmaceutical Europe and H. Lundbeck A/S have announced that the European Commission has approved Abilify Maintena 960 mg (aripiprazole) as a once-every-two-months long-acting injectable (LAI) formulation for the treatment of schizophrenia.
Corteria Pharmaceuticals have announced the initiation of its Phase 1 study to evaluate the company’s first-in-class corticotropin-releasing hormone receptor 2 (CRF2) agonist, COR-1167, for the treatment of Worsening Heart Failure.
Novo Nordisk have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended marketing authorisation for Awiqli for treatment of diabetes in adults.
It’s long been a concern for scientists and regulators that drugs are intended for use by anyone but are predominantly tested on one group – white men. Richard Staines reports on how this could change.
Madrigal Pharmaceuticals have announced that the U.S. FDA has granted accelerated approval for Rezdiffra (resmetirom) in conjunction with diet and exercise for the treatment of adults with noncirrhotic NASH.
Biocon Biologics Limited have announced a long -term commercial collaboration with Eris Lifesciences to expand patient access to its portfolio of Metabolics, Oncology, and Critical Care products in India.
Speaking at an event in Edinburgh, Chris Dougray, Head of Development at CBRE Scotland, and Chris Williams, CBRE’s Head of Life Sciences, joined forces to examine the burgeoning sector’s place in Scotland.
